Approvals/CIMA-AEMPS/TAPENTADOL TEVA 250 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Approved

STANDARD

TAPENTADOL TEVA 250 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Teva Pharma S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d1a9ebbeb200b032
Drug Cima Aemps Name: TAPENTADOL TEVA 250 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number: 88381
Holder Company Name: Teva Pharma S.L.U.
Marketing Company Name: Teva Pharma S.L.U.
Authorization Date: 2022-12-09
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 250 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized: Yes
Company Name: Teva Pharma S.L.U.

TAPENTADOL FOSFATO

382,84 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 9, 2022

Approval ID

d1a9ebbeb200b032

Type

Standard